MAP1LC3A and hepatocellular carcinoma: Compared to this group, patients with low LC3 in both tissues (−/−; 18.5% and 55.6%, respectively), those low LC3 in HCC tissues only (−/+; 11.7% and 30.5%, respectively) and those low LC3 in ANT tissues only (+/−; 6.7% and 33.3%, respectively) were significantly more prone to early recurrence (Fig. 2c).